The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation

Systematic glucocorticosteroids (GCS) are used to treat chronic obstructive pulmonary disease (COPD) and can cause leukocytosis. Distinguishing the effect of GCS on leukocyte level from infection-induced leukocytosis is important. We sought to quantify the effect of chronic GCS treatment on leukocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Frenkel, Amit, Kachko, Eric, Novack, Victor, Klein, Moti, Brotfain, Evgeni, Koyfman, Leonid, Maimon, Nimrod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833099/
https://www.ncbi.nlm.nih.gov/pubmed/31623128
http://dx.doi.org/10.3390/jcm8101697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833099/
https://www.ncbi.nlm.nih.gov/pubmed/31623128
http://dx.doi.org/10.3390/jcm8101697

Ejemplares similares